Park Pil-Gu, Fatima Munazza, An Timothy, Moon Ye-Eun, Woo Seungkyun, Youn Hyewon, Hong Kee-Jong
Department of Microbiology, Gachon University College of Medicine, Incheon, Korea.
Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Korea.
Clin Exp Vaccine Res. 2024 Jan;13(1):21-27. doi: 10.7774/cevr.2024.13.1.21. Epub 2024 Jan 31.
Chronic infectious diseases refer to diseases that require a long period of time from onset to cure or death, the use of therapeutic vaccines has recently emerged to eradicate diseases. Currently, clinical research is underway to develop therapeutic vaccines for chronic infectious diseases based on various vaccine formulations, and the recent success of the messenger RNA vaccine platform and efforts to apply it to therapeutic vaccines are having a positive impact on conquering chronic infectious diseases. However, since research on the development of therapeutic vaccines is still relatively lacking compared to prophylactic vaccines, there is a need to focus more on the development of therapeutic vaccines to overcome threats to human health caused by chronic infectious diseases. In order to accelerate the development of therapeutic vaccines for chronic infectious diseases in the future, it is necessary to establish a clear concept of therapeutic vaccines suitable for the characteristics of each chronic infectious disease, as well as standardize vaccine effectiveness evaluation methods, secure standards/reference materials, and simplify the vaccine approval procedure.
慢性传染病是指从发病到治愈或死亡需要很长时间的疾病,最近出现了使用治疗性疫苗来根除疾病的情况。目前,正在开展临床研究,以基于各种疫苗制剂开发用于慢性传染病的治疗性疫苗,信使核糖核酸疫苗平台最近取得的成功以及将其应用于治疗性疫苗的努力,正在对攻克慢性传染病产生积极影响。然而,由于与预防性疫苗相比,治疗性疫苗的研发研究仍然相对较少,因此需要更加关注治疗性疫苗的研发,以克服慢性传染病对人类健康造成的威胁。为了在未来加速慢性传染病治疗性疫苗的开发,有必要建立适合每种慢性传染病特征的明确的治疗性疫苗概念,以及规范疫苗有效性评估方法、确保标准/参考材料,并简化疫苗审批程序。